AJ502

 

AJ502 is a novel, potent, and selective PDE4 inhibitor that has good skin permeating characteristics. Topically administered AJ502 showed efficacy in IMQ-induced psoriasis and PMA-induced atopic dermatitis in the animal models superior to that of marketed comparators. AJ502 is at IND-enabling stage.